Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Acetyl L-carnitine (ALCAR) is a naturally occurring derivative of the amino acid L-carnitine, involved in mitochondrial energy metabolism. Its use for supporting poor circulation has some scientific basis, but the evidence is modest and primarily pertains to specific populations. Several clinical studies have investigated ALCAR in the context of peripheral arterial disease (PAD), a condition characterized by reduced blood flow to the limbs. Randomized controlled trials, such as those published in "Circulation" (Hiatt et al., 2001), have shown that ALCAR supplementation can improve walking distance and reduce symptoms of intermittent claudication in PAD patients, suggesting enhanced circulation and muscle oxygenation. The proposed mechanism involves improved mitochondrial function and fatty acid oxidation in skeletal muscles, potentially leading to better energy utilization and delayed onset of muscle fatigue. However, while these findings are promising, the effect sizes are moderate, and not all studies report significant clinical benefits. Most research has focused on individuals with diagnosed vascular issues rather than the general population experiencing "poor circulation." There is limited evidence for its use in other circulatory disorders or for general circulatory support in healthy individuals. The safety profile of ALCAR is generally good, but its efficacy for poor circulation outside of PAD remains inadequately substantiated. More large-scale, high-quality trials are needed to confirm its broader circulatory benefits.

More about acetyl l-carnitine
More about Circulation (poor)

Other ingredients used for Circulation (poor)

Other health conditions supported by acetyl l-carnitine

Products containing acetyl l-carnitine

Nature's Sunshine Solstic Cardio